Cargando…
Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial
We evaluated the impact of intensive smoking cessation activities as an adjunct to anti-tuberculosis treatment on patient-related treatment outcomes. In this open-label, randomised controlled trial, self-reporting smokers with pulmonary tuberculosis who initiated standard anti-tuberculosis treatment...
Autores principales: | Sharma, Surendra Kumar, Mohan, Alladi, Singh, Achintya Dinesh, Mishra, Hridesh, Jhanjee, Sonali, Pandey, Ravindra Mohan, Singh, Binit Kumar, Sharma, Rohini, Pallipamu, Prakash Babu, Pai, Madhukar, Dheda, Keertan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995820/ https://www.ncbi.nlm.nih.gov/pubmed/29891957 http://dx.doi.org/10.1038/s41598-018-26990-5 |
Ejemplares similares
-
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019) -
High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India
por: Sharma, Rohini, et al.
Publicado: (2019) -
Challenges in the diagnosis & treatment of miliary tuberculosis
por: Sharma, Surendra K., et al.
Publicado: (2012) -
Miliary tuberculosis: A new look at an old foe
por: Sharma, Surendra K., et al.
Publicado: (2016) -
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium
por: Sharma, Surendra K., et al.
Publicado: (2013)